Patanjali episode raises larger regulatory issues 0 02.05.2024 18:20 Thehindubusinessline.com There are two regulatory lacuna — one that pertains to mis-selling, which the Supreme Court called out in its April 23 hearing with respect to Patanjali, and the second that deals with the approval of proprietary AYUSH medicines Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
